IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q2 2020 Holdings

Filed 2020-08-14 | 12 holdings | $208.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$172.0M643,00082.6%
Abbvie Inc(ABBV)COM00287Y109$30.5M310,15014.6%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$5.1M1,075,0002.5%
Alkermes PLC(ALKS)SHSG01767105$151.8K7,825,0000.1%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$144.9K14,040,0000.1%
Jazz Pharmaceuticals PLC(JAZZ)SHS USDG50871105$102.4K928,1000.0%
Innoviva Inc(INVA)COM45781M101$89.7K6,414,0000.0%
Alexion Pharmaceuticals Inc(ALXN)COM015351109$83.5K743,5000.0%
Mersana Therapeutics IncCOM59045L106$60.1K2,570,0000.0%
Intercept Pharmaceuticals Inc(ICPTUSD)COM45845P108$57.5K1,201,0000.0%
Regulus Therapeutics IncCOM NEW75915K200$1.3K1,851,8510.0%
Mirati Therapeutics Inc(MRTXEUR)COM60468T105$1141,0000.0%